Each year millions of young children undergo procedures requiring sedation or general anesthesia. An increasing proportion of the anesthetics used are provided to optimize diagnostic imaging studies such as magnetic resonance imaging. Concern regarding the neurotoxicity of sedatives and anesthetics has prompted the US Food and Drug Administration to change labeling of anesthetics and sedative agents warning against repeated or prolonged exposure in young children. This review aims to summarize the risk of anesthesia in children with an emphasis on anesthetic-related neurotoxicity, acknowledge the value of pediatric neuroimaging, and address this call for conversation.
There is heightened concern surrounding the safety of sedation and anesthetic medications in young children. Animal studies consistently report brain injury and behavior changes in animals exposed to sedatives during critical periods of brain development. Likewise, evolving yet inconsistent human studies suggest an association between anesthetic exposure and cognitive delay. This theoretical risk of anesthetic-related neurotoxicity must be placed in the context of the known risks of procedural sedation and perceived benefits of the indicated procedure. SmartTots, a Public-Private Partnership between the US Food and Drug Administration (FDA) and the International Anesthesia Research Society, recently released a revised consensus statement recommending a conversation "among all members of the care team as well as the family" regarding timing of procedures or tests that require anesthesia while affirming that anesthetic drugs are a necessary part of diagnostic studies in infants and toddlers that cannot be delayed. [1] [2] [3] This statement is endorsed by 19 leading US and global health organizations, including the American Academy of Pediatrics and the Society for Pediatric Anesthesia, and recommends that "concerns regarding the unknown risk of anesthetic exposure to [the] child's brain development must be weighed against the potential harm associated with cancelling or delaying a needed procedure." 3 More recently, the FDA announced the addition of a warning to be added to labels of general anesthetic and sedation medications, indicating that "repeated and lengthy (>3 hours) use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women in the third trimester may affect the child's developing brain." 4 Neuroimaging is an increasingly common indication for sedation or general anesthesia in young children. Because child neurologists may be unfamiliar with the risks of general anesthesia/sedation and anesthesiologists may be unfamiliar with the clinical indications for neuroimaging, the authors aim to unite both specialties and review the risks of anesthesia and sedation in young children with an emphasis on anesthetic-related neurotoxicity, discuss the value of pediatric neuroimaging, and impart a framework from which this conversation might occur.
Risk of Anesthesia in Children
The safety of pediatric anesthesia has increased over the past several decades, with improved monitoring, equipment, medications, and growing subspecialization and regionalization of pediatric care. 5, 6 Despite these advances, anesthetic-related complications occur more often in children compared to adults. 7, 8 Specifically, infants and children younger than 3 years and children with comorbid conditions are at the highest risk of morbidity associated with general anesthesia. 7, 9, 10 Reasons for this increased anesthetic risk in young children are multifactorial and include limited cardiopulmonary reserve, multiorgan immaturity, altered total body water composition relative to adults, limited pharmacokinetic and pharmacodynamics data on commonly used medications in children, altered sensitivity to drugs relative to older children, temperature lability, care team experience, and monitoring difficulties, especially in magnetic resonance imaging (MRI) suites secondary to magnetic interference. 11
Anesthesia-Related Neurotoxicity
Animal research reporting permanent neurocognitive impairment has created new concerns regarding the safety of anesthetics and sedatives in young children, generating significant attention and concern among health care providers and parents alike. Preclinical studies of anesthetic neurotoxicity originate from mechanistic studies of fetal alcohol syndrome, a wellknown, well-characterized, permanent neurotoxidrome. [12] [13] [14] [15] [16] A sentinel study found that exposure of developing rodents to ethanol, a known N-methyl-D-aspartate (NMDA) receptor antagonist and g-aminobutyric acid (GABA) receptor agonist, during periods of synaptogenesis caused widespread apoptotic neurodegeneration of the rat forebrain. 14 Because nearly all anesthetic and sedative agents are believed to modulate either NMDA-or GABA-mediated signaling, it was hypothesized that exposure of developing animals to common sedatives modulating these receptors might induce a similar degree of neuronal cell death as that reported for ethanol. Over the last 15 years, there have been innumerable reports demonstrating widespread neurodegeneration in response to essentially all known sedatives and anesthetics with overt concern for longterm developmental impairment. These histologic changes have reported developmental significance as the combination of midazolam, nitrous oxide, and isoflurane induced both neuroapoptosis and persistent memory and learning impairments in infant rats. 17 These data have also been replicated in nonhuman primates, demonstrating both neuroapoptosis and persistent deficits in motivation, color and position discrimination tasks, response speed, and task performance accuracy after a single exposure to 24 hours of ketamine during the first week of life. Of note, these animals are presently more than 5 years old and continue to demonstrate decreased task performance relative to controls. 18 A recent systematic review of preclinical anesthetic neurotoxicity studies in MEDLINE revealed close to 1000 articles published since 2004 related to this subject. 13 Despite heterogeneous methodologies impairing direct comparison, preclinical studies suggest a window of vulnerability for anesthesia-induced neuronal cell death, the presence of a dose-dependent neurotoxic response to anesthetics, and amplified toxicity with multiple exposures to the same anesthetic agent. 13, 19 Replication of these animal studies in humans is not ethically possible, and direct translation of these results to clinical medicine is impossible. Thus, retrospective epidemiologic studies and emerging prospective clinical trials have been conducted or are currently under way to better understand the relevance of preclinical studies to young children, if any. [20] [21] [22] [23] [24] [25] [26] Despite known limitations of retrospective studies, heterogeneity in methodology, degree of confounding, and differing outcome measurements, a cumulative analysis suggests an association between adverse neurodevelopmental outcomes and exposure of anesthesia at an early age. 12 The strength of this association is weak, however, with the majority of studies reporting hazard ratios less than 2. 27, 28 Despite their limitations, extant studies suggest that single brief anesthetic exposures do not appear to produce a measurable effect whereas repeated exposures consistently demonstrate associations between exposure and subsequent deficits in learning and behavior (Figure 1 ). 21 The potential ramifications of the associations thus described emphasize the importance of the ongoing prospective studies to parents, providers, and regulators. The General Anesthesia Compared to Spinal Anesthesia (GAS) trial, an international multisite randomized controlled trial, was designed to study cognitive outcomes at 2 and 5 years of age in more than 700 neonates randomized to either general or spinal anesthesia for hernia surgery. 26 Recent analysis of the secondary outcome (neurodevelopment at 2 years of age) found no evidence of adverse neurodevelopment at 2 years of age in infants receiving less than 1 hour of general anesthesia with sevoflorane compared with awake-regional anesthesia. 26 Similarly, the multicenter Pediatric Anesthesia NeuroDevelopment Assessment (PANDA) study examined the effect of a single brief anesthetic on performance in a sibling cohort discordant for exposure to general anesthesia for inguinal hernia repair. Like the GAS study, the PANDA study examined the effect of a single brief exposure and was also negative. [29] [30] [31] In this multisite sibling-matched cohort study, healthy children exposed to a single anesthetic before 36 months of age compared to healthy siblings without anesthesia exposure had no difference in IQ scores in later childhood. 31 The Mayo Anesthesia Safety in Kids (MASK) study is a collaboration between Mayo Clinic and the National Center for Toxicological Research (NCTR). 30 It is a population-based propensity-matched study comparing performance on neuropsychologic testing (NCTR-Operant Test Battery) of children who were exposed to anesthesia prior to 3 years of age with unexposed children. The Operant Test Battery has been used to study anesthetic-related neurotoxicity in nonhuman primates and offers a direct comparison of effects of anesthetic exposure in children and nonhuman primates performing identical behavioral tasks. 30 Human studies examining anesthesia and surgery associated neurodevelopmental outcomes are summarized in Table 1 . 32 Until further studies clarify the effect of anesthesia on neurodevelopmental outcome in young children, the risks remain unknown and health care teams are left to weigh the known risks (eg, aspiration, bronchospasm, laryngospasm, cardiac arrest) and unknown risks (eg, anesthetic-related neurotoxicity) of anesthesia with the perceived benefits of diagnostic procedures. 3
Sedation-Related Neurotoxicity
As alluded to above, it is important to note that the label anesthetic neurotoxicity may be a misnomer because the implicated medications are widely used outside of the conduct of a general anesthetic. Equally important, subanesthetic doses of these sedatives demonstrate neurodegeneration in laboratory animals. 40 The same medications used during the course of a general anesthetic are commonly used for sedation for diagnostic and therapeutic procedures outside of the operating room. Exposure to these medications, particularly in the intensive care unit, may be of particular importance as doses are commonly high and exposure time prolonged. [41] [42] [43] [44] [45] [46] 
Value of Neuroimaging in Children
Neuroimaging in infants and young children often requires sedation or general anesthesia for both patient comfort and accurate interpretation of study results. The value or diagnostic yield of imaging in children is a complicated discussion reflecting the heterogeneity of clinical indications. Most studies assessing imaging yield describe how often pertinent positive findings are identified that change acute management; however, the ability of imaging to rule out pathology is often equally important and its value understated. Diagnostic yield varies between organ systems, diagnoses within the same system, and even within the same general diagnosis. The pediatric neuroimaging guidelines set by the American Academy of Neurology depend on whether a child is being evaluated for microcephaly, status epilepticus, global developmental delay, or cerebral palsy. 47 A child presenting with classic clinical and electroencephalographic features of a genetic, generalized epilepsy and a normal examination does not necessarily need neuroimaging, whereas neuroimaging is recommended in a child with focal epilepsy and an abnormal examination. The strength of evidence for neuroimaging varies by diagnosis. For instance, a substantial number of children with new-onset seizure and status epilepticus will have urgent or emergent intracranial pathology identified on neuroimaging, whereas the vast majority of children with mild traumatic brain injury do not require neuroimaging. 48, 49 The risk-benefit analysis regarding imaging decision making is complex. This includes decisions on the optimal imaging modality and optimal timing to obtain or repeat imaging. For example, an infant with hypoxic-ischemic encephalopathy may benefit more from a brain MRI compared with computed tomographic (CT) study, but the imaging timing may depend on several factors, including concomitant therapeutic hypothermia. 50 Although CT studies rarely require anesthesia in children, the diagnostic yield of a head CT can be limited and the risk associated with ionizing radiation in children is a major concern. 51-53 A retrospective study of pediatric CT scan use in the United Kingdom reported a dose-response relationship between risk of leukemia and brain cancer and ionizing radiation exposure-a dose-response relationship compatible with that observed in Japanese atomic bomb survivors. 51, 54 Re-analysis of the cohort excluding participants with 
596
Journal of Child Neurology 32(6) Compared with unexposed peers, exposed children had an increased risk of deficit in neuropsychological language assessments (CELF) and ICD-9 coded language and cognitive disorders, but not academic achievement scores (continued) cancer-predisposing conditions continued to show increased cancer risk after low-dose radiation exposure from CT scans in young children. 54 Although the Joint Commission and the American College of Radiology promote the reduction of CT use in children, the long-term impact of recent CT dosereduction strategies on the risk of cancer in children is unknown. 55 Even though MRI does not expose children to radiation, risk exists apart from anesthesia as there is a strong association between gadolinium-based contrast agents used in MRI and nephrogenic systemic fibrosis (NSF) in patients with renal impairment and pro-inflammatory conditions. 56 Although this multisystem disease is rare, with 10 biopsy-proven cases reported in children, it can be fatal. 56 Once a decision is made to pursue imaging, it is worth noting that options exist to help minimize risk. MRIcompatible neonatal incubators can help minimize transportassociated risk, 57 and neonates can often tolerate an MRI while sleeping without the need for anesthesia. The frequency of unsedated MRIs in neonates is increasing, especially as MRI acquisition techniques advance to diminish movement artifact. 58 Ultra-fast techniques are available for some diagnostic studies, and evidence supports the use of ultra-fast MRI for the assessment of ventricular size in children with shunttreated hydrocephalus. 58, 59 Finally, consideration may be given to combining multiple studies and procedures requiring anesthesia in children to limit exposure; however, an individual risk-benefit analysis in the context of the present health care practice may not support this as risk of transport and additional anesthesia exposure between studies may outweigh the perceived benefit.
Call for Conversation
When neuroimaging is necessary in young children, the prescribing physician is the ideal person to initiate a conversation with the family and care team regarding timing and outcome-changing potential of the requested study. Because most MRI studies in young children require sedation or general anesthesia, and sedation is no safer than general anesthesia, pediatric neurologists should be familiar with the risks in order to best navigate this discussion and address parental concerns, especially because parents are the ultimate patient advocate and consumer of mainstream media and are increasingly questioning the risk.
Because families differ in regard to the information desired, it is the authors' practice to take an individualized approach by discussing risks of anesthesia in general terms and inviting parents and older children to ask for more specific information. Because the risk of anesthetic-related neurotoxicity is unknown and theoretical, no mention of this topic is made unless requested. Consistent with our practice, a recent survey of current pediatric anesthesia practices at US teaching institutions found that more than 90% of pediatric anesthesiologists discuss the issue of neurotoxicity "only if asked." 60 When parents and older children do ask, the authors welcome the conversation and provide reassurance that a single, short exposure of general anesthesia does not appear to increase the risk of an adverse neurodevelopmental outcome. 26, 31 In addition, we share with inquisitive parents the low rate of harm associated with anesthesia and lack of compelling evidence to date of a causal relationship between anesthetic exposure and developmental delay. Because anesthesiologists often meet their patients on the day of the scheduled study when parents are anxious and children are fasting, child neurologists can help their colleagues in anesthesiology by preemptively addressing parental questions and affirming the importance of the recommended study to families, emphasizing how the test result will directly alter the child's treatment plan and health outcome. Furthermore, pediatric anesthesiologists would willingly assist their colleagues in pediatric neurology with this discussion and welcome preprocedural consultation as questions and concerns arise.
Until further research clarifies the impact of anesthetic and sedative medications on neurodevelopment or until neuroimaging technology advances beyond the need for general anesthesia for these studies in young children, pediatric neurologists and anesthesiologists should work together, engaging in conversation to provide the best care, minimizing risk, and maximizing benefit for the health of all children. 61 
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